Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey
Cheryl Vidall, Florian Scotté(Université Paris-Saclay), Paz Fernández‐Ortega(Institut Català d'Oncologia), Bharat Amlani(Norgine (United Kingdom)), Patrick Jahn(Martin Luther University Halle-Wittenberg), Diego Cortinovis(Azienda Ospedaliera San Gerardo)
Cited by 58
Related Papers
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
|Annals of Oncology|2020|319
Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life
|Supportive Care in Cancer|2012|175
Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
|Annals of Oncology|2018|169